BMS-817399

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-817399, covering 2015-10-12 to 2015-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis [Phase 2]